3715: Is Retatrutide Better Than Ozempic?
April 8, 2026
3715: Is Retatrutide Better Than Ozempic?
April 8, 2026
WW:
Is the newest weight loss drug really “Ozempic on steroids”… or is that just hype?
On today’s episode, we break down the science behind Retatrutide, a new GLP-1–based peptide being compared to Ozempic for its potential to drive even greater weight loss.
While early research suggests it may be more powerful due to its triple-action mechanism, the real-world results and risks may not be as clear-cut as the headlines suggest.
You’ll learn how these medications actually work in the body, the difference between single vs. triple agonists, and why more weight loss doesn’t always mean better outcomes, especially when muscle loss, metabolism, and long-term sustainability are considered.
We’ll also review the current research, side effects, and what to consider before choosing either option.
So join me on Cabral Concept 3715 to learn if Retatrutide is better than Ozempic and uncover what’s real, what’s hype, and how to make the most informed decision for your health and weight loss journey.
Enjoy the show, and let me know your thoughts!
Show Highlights & Big Takeaways
Retatrutide is More Powerful, But Not Dramatically (Yet): While it works on three pathways and may lead to greater weight loss, current data shows only about a 2–3% improvement over Ozempic, not the massive difference often advertised.
More Mechanisms = More Potential Risks: Because Retatrutide is a triple agonist, it may come with more side effects and unknown long-term risks, including GI issues, nerve-related symptoms, and possible heart concerns.
Strategy Matters More Than the Drug: Both medications can lead to significant weight loss, but without a plan (strength training, nutrition, tapering off), users risk muscle loss, metabolic slowdown, and regaining weight later.
